Retail News
Panel Opposes OTC Approval for Mevacor
Reuters 01/14/2005Concerns about whether the drug could be used safely without a doctor’s guidance has led an advisory panel to argue against regulators approving the cholesterol drug, Mevacor, for sale over-the-counter.
Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!